Halozyme Therapeutics Inc. (HALO) News Nov 20, 201
Post# of 250602
Posted On: 11/20/2014 8:38:53 PM
Halozyme Therapeutics Inc. (HALO) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on HALO
Fossil Group swings higher on earnings beat, license renewal 6:30 a.m. Nov. 12, 2014 - Wallace Witkowski
Amazon gains on June event; PVH sinks on results 2:36 p.m. June 5, 2014 - Sue Chang
Stock futures rise after ECB moves, claims report 8:00 a.m. June 5, 2014 - Barbara Kollmeyer
ECB, jobs report could finally ignite the stock-market powder keg 7:46 a.m. June 5, 2014 - Shawn Langlois
PVH falls, Halozyme, Five Below, gain after hours 3:51 p.m. June 4, 2014 - Myra P. Saefong
Rackspace shares surge after hours on earnings 5:10 p.m. May 12, 2014 - Wallace Witkowski
Halozyme temporarily halts dosing in cancer study 8:27 a.m. April 4, 2014 - MarketWatch.com
A Morgan Stanley buy, Alcoa's report and the streaker opens up 7:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 11:40 a.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 5:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 1:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 5:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 3:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
Halozyme rebounds 12% in midday trading 10:21 a.m. Aug. 3, 2012 - Val Brickates Kennedy
Other News on HALO
Biggest Movers in Healthcare Stocks Now – CLDX ALGN WST PDCO 12:45 p.m. Nov. 12, 2014 - InvestorPlace.com
Halozyme Therapeutics (HALO) Stock Is Slipping Today on Weak Third Quarter Earnings 11:42 a.m. Nov. 11, 2014 - TheStreet.com
Halozyme Therapeutics' (HALO) CEO Helen Torley on Q3 2014 Results - Earnings Call Transcript 9:33 p.m. Nov. 10, 2014 - Seeking Alpha
10-Q: HALOZYME THERAPEUTICS INC 4:50 p.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Halozyme Therapeutics Plummets On Q3 Losses 4:19 p.m. Nov. 10, 2014 - benzinga.com
NewLink Genetics Corporation (NLNK) in Focus: Stock Soars 15.4% - Tale of the Tape 9:18 a.m. Oct. 23, 2014 - Zacks.com
Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing - Analyst Blog 5:54 p.m. Oct. 22, 2014 - Zacks.com
Biogen's Q3 Earnings Top Estimates, View Raised Again - Analyst Blog 1:10 p.m. Oct. 22, 2014 - Zacks.com
Actelion Misses Q3 Earnings Expectation, Ups 2014 Guidance - Analyst Blog 11:40 a.m. Oct. 22, 2014 - Zacks.com
Orexigen (OREX) Shows Strength: Stock Gains 11.1% - Tale of the Tape 9:25 a.m. Oct. 22, 2014 - Zacks.com
Illumina (ILMN) Looks Strong: Stock Gains 9.2% - Tale of the Tape 8:44 a.m. Oct. 22, 2014 - Zacks.com
NewLink-Roche Ink Deal for Oncology Candidate Development - Analyst Blog 6:05 p.m. Oct. 21, 2014 - Zacks.com
Illumina (ILMN) Tops Q3 Earnings, Revenues; Ups Guidance - Analyst Blog 9:40 a.m. Oct. 21, 2014 - Zacks.com
Vital Therapies (VTL) in Focus: Stock Adds 7.9% in Session - Tale of the Tape 9:39 a.m. Oct. 21, 2014 - Zacks.com
NewLink Genetics Corp. (NLNK) Jumps: Stock Rises 7.1% - Tale of the Tape 8:51 a.m. Oct. 21, 2014 - Zacks.com
Amicus Reports Additional Positive Data on Fabry Therapy - Analyst Blog 6:35 p.m. Oct. 20, 2014 - Zacks.com
Regeneron Pharmaceuticals (REGN) Jumps: Stock Up 8.5% - Tale of the Tape 9:39 a.m. Oct. 20, 2014 - Zacks.com
Emergent BioSolutions (EBS) Jumps: Stock Moves Up 5.8% - Tale of the Tape 8:51 a.m. Oct. 20, 2014 - Zacks.com
Ultragenyx Reports Data from Sialic Acid Deficiency Study - Analyst Blog 5:00 p.m. Oct. 17, 2014 - Zacks.com
Novavax (NVAX) Moves Up: Stock Adds 10.1% in Session - Tale of the Tape 9:39 a.m. Oct. 17, 2014 - Zacks.com
Press Releases on HALO
Halozyme Reports Third Quarter 2014 Financial Results 4:05 p.m. Nov. 10, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference 4:15 p.m. Nov. 5, 2014 - PR Newswire - PRF
Halozyme to Host Third Quarter 2014 Financial Results Conference Call 4:15 p.m. Nov. 3, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 7:40 a.m. Oct. 31, 2014 - PR Newswire - PRF
Baxter Launches HYQVIA in the United States for Adult Patients with Primary Immunodeficiency 8:02 a.m. Oct. 20, 2014 - BusinessWire - BZX
Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant 7:30 a.m. Oct. 20, 2014 - PR Newswire - PRF
Halozyme Announces Podium Presentation On PEGPH20 At The New York Academy Of Sciences 8:00 a.m. Oct. 9, 2014 - PR Newswire - PRF
Halozyme Announces Issuance Of U.S. Patent For Companion Diagnostic For PEGPH20 7:30 a.m. Oct. 7, 2014 - PR Newswire - PRF
Halozyme Receives Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer 6:45 a.m. Oct. 3, 2014 - PR Newswire - PRF
SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 8:00 a.m. Sept. 18, 2014 - PR Newswire - PRF
Biotech Stocks in Motion - XOMA, Nanosphere, Isis Pharma, Halozyme Therapeutics, and Synta Pharma 7:45 a.m. Sept. 17, 2014 - PR Newswire - PRF
FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency 6:02 p.m. Sept. 12, 2014 - BusinessWire - BZX
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation 7:30 a.m. Sept. 3, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Halozyme to Host second Quarter 2014 Financial Results Conference Call 3:30 p.m. Aug. 4, 2014 - PR Newswire - PRF
FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter’s HyQvia for Primary Immunodeficiency 12:55 p.m. July 31, 2014 - BusinessWire - BZX
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 8:00 a.m. July 22, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 6:20 a.m. July 10, 2014 - PR Newswire - PRF
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health 5:20 a.m. July 2, 2014 - PR Newswire - PRF
Roche's Commercial Launch Of MabThera SC Triggers Milestone Payment To Halozyme 7:00 a.m. June 25, 2014 - PR Newswire - PRF
MarketWatch News on HALO
Fossil Group swings higher on earnings beat, license renewal 6:30 a.m. Nov. 12, 2014 - Wallace Witkowski
Amazon gains on June event; PVH sinks on results 2:36 p.m. June 5, 2014 - Sue Chang
Stock futures rise after ECB moves, claims report 8:00 a.m. June 5, 2014 - Barbara Kollmeyer
ECB, jobs report could finally ignite the stock-market powder keg 7:46 a.m. June 5, 2014 - Shawn Langlois
PVH falls, Halozyme, Five Below, gain after hours 3:51 p.m. June 4, 2014 - Myra P. Saefong
Rackspace shares surge after hours on earnings 5:10 p.m. May 12, 2014 - Wallace Witkowski
Halozyme temporarily halts dosing in cancer study 8:27 a.m. April 4, 2014 - MarketWatch.com
A Morgan Stanley buy, Alcoa's report and the streaker opens up 7:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 11:40 a.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 5:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 1:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 5:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 3:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
Halozyme rebounds 12% in midday trading 10:21 a.m. Aug. 3, 2012 - Val Brickates Kennedy
Other News on HALO
Biggest Movers in Healthcare Stocks Now – CLDX ALGN WST PDCO 12:45 p.m. Nov. 12, 2014 - InvestorPlace.com
Halozyme Therapeutics (HALO) Stock Is Slipping Today on Weak Third Quarter Earnings 11:42 a.m. Nov. 11, 2014 - TheStreet.com
Halozyme Therapeutics' (HALO) CEO Helen Torley on Q3 2014 Results - Earnings Call Transcript 9:33 p.m. Nov. 10, 2014 - Seeking Alpha
10-Q: HALOZYME THERAPEUTICS INC 4:50 p.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Halozyme Therapeutics Plummets On Q3 Losses 4:19 p.m. Nov. 10, 2014 - benzinga.com
NewLink Genetics Corporation (NLNK) in Focus: Stock Soars 15.4% - Tale of the Tape 9:18 a.m. Oct. 23, 2014 - Zacks.com
Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing - Analyst Blog 5:54 p.m. Oct. 22, 2014 - Zacks.com
Biogen's Q3 Earnings Top Estimates, View Raised Again - Analyst Blog 1:10 p.m. Oct. 22, 2014 - Zacks.com
Actelion Misses Q3 Earnings Expectation, Ups 2014 Guidance - Analyst Blog 11:40 a.m. Oct. 22, 2014 - Zacks.com
Orexigen (OREX) Shows Strength: Stock Gains 11.1% - Tale of the Tape 9:25 a.m. Oct. 22, 2014 - Zacks.com
Illumina (ILMN) Looks Strong: Stock Gains 9.2% - Tale of the Tape 8:44 a.m. Oct. 22, 2014 - Zacks.com
NewLink-Roche Ink Deal for Oncology Candidate Development - Analyst Blog 6:05 p.m. Oct. 21, 2014 - Zacks.com
Illumina (ILMN) Tops Q3 Earnings, Revenues; Ups Guidance - Analyst Blog 9:40 a.m. Oct. 21, 2014 - Zacks.com
Vital Therapies (VTL) in Focus: Stock Adds 7.9% in Session - Tale of the Tape 9:39 a.m. Oct. 21, 2014 - Zacks.com
NewLink Genetics Corp. (NLNK) Jumps: Stock Rises 7.1% - Tale of the Tape 8:51 a.m. Oct. 21, 2014 - Zacks.com
Amicus Reports Additional Positive Data on Fabry Therapy - Analyst Blog 6:35 p.m. Oct. 20, 2014 - Zacks.com
Regeneron Pharmaceuticals (REGN) Jumps: Stock Up 8.5% - Tale of the Tape 9:39 a.m. Oct. 20, 2014 - Zacks.com
Emergent BioSolutions (EBS) Jumps: Stock Moves Up 5.8% - Tale of the Tape 8:51 a.m. Oct. 20, 2014 - Zacks.com
Ultragenyx Reports Data from Sialic Acid Deficiency Study - Analyst Blog 5:00 p.m. Oct. 17, 2014 - Zacks.com
Novavax (NVAX) Moves Up: Stock Adds 10.1% in Session - Tale of the Tape 9:39 a.m. Oct. 17, 2014 - Zacks.com
Press Releases on HALO
Halozyme Reports Third Quarter 2014 Financial Results 4:05 p.m. Nov. 10, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference 4:15 p.m. Nov. 5, 2014 - PR Newswire - PRF
Halozyme to Host Third Quarter 2014 Financial Results Conference Call 4:15 p.m. Nov. 3, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 7:40 a.m. Oct. 31, 2014 - PR Newswire - PRF
Baxter Launches HYQVIA in the United States for Adult Patients with Primary Immunodeficiency 8:02 a.m. Oct. 20, 2014 - BusinessWire - BZX
Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant 7:30 a.m. Oct. 20, 2014 - PR Newswire - PRF
Halozyme Announces Podium Presentation On PEGPH20 At The New York Academy Of Sciences 8:00 a.m. Oct. 9, 2014 - PR Newswire - PRF
Halozyme Announces Issuance Of U.S. Patent For Companion Diagnostic For PEGPH20 7:30 a.m. Oct. 7, 2014 - PR Newswire - PRF
Halozyme Receives Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer 6:45 a.m. Oct. 3, 2014 - PR Newswire - PRF
SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 8:00 a.m. Sept. 18, 2014 - PR Newswire - PRF
Biotech Stocks in Motion - XOMA, Nanosphere, Isis Pharma, Halozyme Therapeutics, and Synta Pharma 7:45 a.m. Sept. 17, 2014 - PR Newswire - PRF
FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency 6:02 p.m. Sept. 12, 2014 - BusinessWire - BZX
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation 7:30 a.m. Sept. 3, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Halozyme to Host second Quarter 2014 Financial Results Conference Call 3:30 p.m. Aug. 4, 2014 - PR Newswire - PRF
FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter’s HyQvia for Primary Immunodeficiency 12:55 p.m. July 31, 2014 - BusinessWire - BZX
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 8:00 a.m. July 22, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 6:20 a.m. July 10, 2014 - PR Newswire - PRF
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health 5:20 a.m. July 2, 2014 - PR Newswire - PRF
Roche's Commercial Launch Of MabThera SC Triggers Milestone Payment To Halozyme 7:00 a.m. June 25, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼